FEATURED EDITORIAL
mRNA medicines represent the genesis of a fourth pillar of pharma innovation. While exciting, there are several critical challenges we must solve to strengthen this pillar, including stability and deliverability.
- Cell Counting Is Growing More Important Amid Advanced Therapy’s Rise
- A Promising Approach To Develop An Inhalable, Temperature-Stable COVID-19 Vaccine
- AI Is Unearthing New Drug Candidates, But It Still Needs Human Oversight
- 2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies
- AI And Pharmaceutical Development: WHO Calls For Ethical Framework, Good Governance
- AI Technologies Drive Drug Development And Enhance Patient Experience In Neurology & Rare Diseases
- 2024 LIMS Trends
FEATURED APPLICATION CONTENT
-
Explore the advantages of utilizing a xeno- and serum-free medium for the targeted expansion of cell subpopulations without the addition of serum.
-
Bulk filling drug substances in traditional facilities is often a lengthy, manual process where operators are relied upon to adjust pump controls to achieve accurate filling. This method, spanning multiple shifts, increases process risk through errors that can compromise accuracy.
-
Learn about a more human-relevant platform that enables researchers to assess the trafficking and killing efficiency of immunotherapy as well as the proof-of-concept of immuno-oncology co-therapy.
-
This study aimed to identify the optimal cell culture conditions to yield high cell density and maintain high cell viability with consistent aggregate morphology and pluripotency marker expression.
-
See how the Colon Intestine-Chip has been employed to model cytokine-mediated inflammation and barrier disruption in the intestine.
-
This study explores whether a species-specific, multicellular, in vitro hepatotoxicity assays utilizing Liver-Chips can provide a greater understanding of hepatotoxicity mechanisms than animal models.
-
Efforts to develop a dynamic “brain-on-a-chip” model that closely resembles the human substantia nigra could be applied to study mechanisms of Parkinson’s disease.
-
Discover a first-of-its-kind human LF-Chip containing B, T, plasma and antigen-presenting cells to test functional immunization responses to vaccines and adjuvants in vitro.
-
A Bone Marrow-Chip (BM-Chip) was created to recapitulate relevant hematopoietic cell types in a three-dimensional (3D), mechanically active next-generation in vitro model.
-
Learn how Organ-Chips are being used to rapidly identify promising treatments, investigate virus evolution, and analyze how mechanical forces influence the innate immune response to viral infections.
-
This study examines the expansion, functionality, and phenotype of CAR-T cells cultured in the CellGenix® GMP T cell culture medium (TCM) compared to other commercially available T cell media.
-
This study demonstrates the automated magnetic isolation of CD4/CD8+ cells from fresh or frozen leukapheresis using a functionally closed cell processing system paired with a modular application.
FEATURED NEWS HEADLINES
- Convenience Meets Compliance: Introducing The Next-Generation Sterility Testing Pump For The Connected Lab
- VantAI Collaborates With Google Cloud To Harness NVIDIA GPUs For Building Protein Interaction Foundation Models
- Tsetse Fly Protein Provides Anti-Clotting Agent With Its Own On-Off Switch
- Ingenium Therapeutics Novel NK Cell Therapy Receives Orphan Drug Designation From FDA
- Eton Pharmaceuticals Announces Submission To FDA Of New Drug Application For ET-400 (Hydrocortisone Oral Solution)
- Eluminex Biosciences Announces FDA Acceptance Of Investigational New Drug (IND) Application For EB-105 - A Novel Trispecific Fusion Antibody For Diabetic Macular Edema (DME) - And Upcoming Scientific Presentations
- Neurocrine Biosciences Announces U.S. FDA Approval Of INGREZZA® SPRINKLE (valbenazine) Capsules
- Every Cure Deploys BioPhy’s Artificial Intelligence Platform To Accelerate Its Mission Of Repurposing Drugs For Untreated Diseases
- New Drug Candidate Reverses Obesity In Mice
- MSD Joins The Open Targets Consortium
ARCHIVED NEWSLETTER
- 05.07.24 -- AI And Pharmaceutical Development: WHO Calls For Ethical Framework, Good Governance
- 04.30.24 -- Enable Local Delivery For Lung Cancer
- 04.30.24 -- 2024 LIMS Trends
- 04.23.24 -- Novel Approaches In Chromatography Process Development
- 04.23.24 -- Drugging The Undruggable: Strategies And Future Directions